(Q46592222)

English

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer

scientific article published in July 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ji-Youn Han

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

Dae Ho Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

Jung Eun Song

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

Sung Young Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

Hyae Young Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

Heung Tae Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

Jin Soo Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

language of work or name

0 references

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

113

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

388-395

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical T

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigating a sequence of randomized phase II trials to discover promising treatments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-small cell lung cancer: second-line and beyond

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of DNA excision repair

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23582

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23582

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

release_vhnj35gty5eptbxythnqhitqpm

1 reference

https://api.fatcat.wiki/v0/release/vhnj35gty5eptbxythnqhitqpm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484595

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46592222&oldid=2121206351"